US Patent Issued to NewAmsterdam Pharma on Aug. 5 for "Salts of obicetrapib and processes for their manufacture and intermediates thereof" (American, Japanese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,221, issued on Aug. 5, was assigned to NewAmsterdam Pharma B.V. (Naarden, Netherlands).

"Salts of obicetrapib and processes for their manufacture and intermediates thereof" was invented by Sheng Cui (Lexington, Mass.), Andreas Rene Rotheli (Wellesley, Mass.), Christopher J. Borths (Sherborn, Miss.), Muneki Kishida (Osaka, Japan) and Valeriya Nikolayevna Smolenskaya (West Lafayette, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is a method for the manufacture of a compound of obicetrapib and salts thereof, such as calcium salts thereof. Also provided herein is amorphous obicetrapib hemicalcium. New intermediates for use in the sy...